923505893	923505893	CD	B-NP	O
|	|	NNP	I-NP	O
RHAC	RHAC	NNP	I-NP	O
|	|	VBD	B-VP	O
04137204	04137204	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
765476	765476	CD	B-NP	O
|	|	CC	I-NP	O
8/27/1996	8/27/1996	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/11/1996	7/11/1996	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/8/1996	1/8/1996	CD	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
INFERIOR/POSTERIOR	INFERIOR/POSTERIOR	NN	B-NP	O
MYOCARDIAL	MYOCARDIAL	NN	I-NP	O
INFARCTION	INFARCTION	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
67	67	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
tachyarrhythmias	tachyarrhythmia	NNS	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
came	come	VBD	B-VP	O
in	in	RP	B-PRT	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
inferior/posterior	inferior/posterior	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Coronary	Coronary	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
after	after	IN	B-PP	O
initiation	initiation	NN	B-NP	O
of	of	IN	B-PP	O
TPA	TPA	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
included	include	VBD	B-VP	O
tobacco	tobacco	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
family	family	NN	B-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
generally	generally	RB	I-NP	O
healthy	healthy	JJ	I-NP	O
female	female	NN	I-NP	O
who	who	WP	B-NP	O
smoked	smoke	VBD	B-VP	O
and	and	CC	I-VP	O
had	have	VBD	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
palpitations	palpitation	NNS	B-NP	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
tachyarrhythmia	tachyarrhythmia	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
junctional	junctional	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	I-NP	O
AIVR	AIVR	NN	I-NP	B-protein
but	but	CC	O	O
no	no	DT	B-NP	O
prior	prior	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Ulven	Ulven	NNP	I-NP	O
for	for	IN	B-PP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
dizziness	dizziness	NN	B-NP	O
with	with	IN	B-PP	O
palpitations	palpitation	NNS	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
work-up	work-up	NN	I-NP	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
24-hour	24-hour	JJ	I-NP	O
Holter	Holter	NNP	I-NP	O
in	in	IN	B-PP	O
8/5	8/5	CD	B-NP	O
with	with	IN	B-PP	O
frequent	frequent	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
premature	premature	JJ	I-NP	O
beats	beat	NNS	I-NP	O
,	,	,	O	O
short	short	JJ	B-NP	O
bursts	burst	NNS	I-NP	O
of	of	IN	B-PP	O
supraventricular	supraventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
periods	period	NNS	I-NP	O
of	of	IN	B-PP	O
junctional	junctional	JJ	B-NP	O
tachyarrhythmia	tachyarrhythmia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
AIVR	AIVR	NN	B-NP	B-protein
which	which	WDT	B-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echo	echo	NN	I-NP	O
in	in	IN	B-PP	O
8/5	8/5	CD	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
LVF	LVF	NN	I-NP	B-protein
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
and	and	CC	O	O
systolic	systolic	JJ	B-NP	O
bowing	bowing	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
exercise	exercise	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
went	go	VBD	B-VP	O
seven	seven	CD	B-NP	O
minutes	minute	NNS	I-NP	O
stopping	stop	VBG	B-VP	O
with	with	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
fatigue	fatigue	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
maximal	maximal	JJ	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
76	76	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
diagnostic	diagnostic	JJ	I-ADJP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
managed	manage	VBN	I-VP	O
on	on	IN	B-PP	O
Procan	Procan	NNP	B-NP	O
alone	alone	RB	B-ADVP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
result	result	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
previously	previously	RB	B-ADVP	O
on	on	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
but	but	CC	O	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
on	on	IN	B-PP	O
it	it	PRP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
active	active	JJ	B-ADJP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
two	two	CD	B-NP	O
miles	mile	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
without	without	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
ankle	ankle	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
claudication	claudication	NN	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
cerebrovascular	cerebrovascular	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
1995	1995	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
awoke	awake	VBD	B-VP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
on	on	IN	B-PP	O
11/27/95	11/27/95	CD	B-NP	O
with	with	IN	B-PP	O
5/10	5/10	CD	B-NP	O
substernal	substernal	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
light	light	NN	B-NP	O
headedness	headedness	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
prior	prior	JJ	I-NP	O
similar	similar	JJ	I-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
became	become	VBD	B-VP	O
nauseated	nauseated	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
diaphoretic	diaphoretic	JJ	I-ADJP	O
without	without	IN	B-PP	O
radiation	radiation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
arms	arm	NNS	I-NP	O
or	or	CC	O	O
back	back	RB	B-ADVP	O
and	and	CC	O	O
no	no	DT	B-NP	O
pleuritic	pleuritic	JJ	I-NP	O
or	or	CC	I-NP	O
positional	positional	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
called	call	VBD	B-VP	O
the	the	DT	B-NP	O
EMT	EMT	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
116/62	116/62	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
NGT	NGT	NN	B-NP	O
spray	spray	NN	I-NP	O
times	time	NNS	I-NP	O
two	two	CD	B-NP	O
en	en	IN	B-PP	O
route	route	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Ward	Ward	NNP	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
0.5	0.5	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
aVF	aVF	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
V6	V6	NN	B-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
recent	recent	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
bleeds	bleed	NNS	B-NP	O
or	or	CC	O	O
cerebrovascular	cerebrovascular	JJ	B-NP	O
accident	accident	NN	I-NP	O
.	.	.	O	O

TPA	TPA	NN	B-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
within	within	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
thirty	thirty	CD	I-NP	O
minutes	minute	NNS	I-NP	O
following	follow	VBG	B-PP	O
arrival	arrival	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
,	,	,	O	O
Heparin	Heparin	NN	B-NP	O
,	,	,	O	O
morphine	morphine	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
aspirin	aspirin	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
within	within	IN	B-PP	O
45	45	CD	B-NP	O
minutes	minute	NNS	I-NP	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
TPA	TPA	NN	I-NP	O
with	with	IN	B-PP	O
return	return	NN	B-NP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
ST	ST	NN	I-NP	I-protein
segments	segment	NNS	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Coronary	Coronary	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL/SURGICAL	MEDICAL/SURGICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Atrial	Atrial	JJ	B-NP	O
tachyarrhythmias	tachyarrhythmia	NNS	I-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
spinal	spinal	JJ	I-NP	O
fusion	fusion	NN	I-NP	O
in	in	IN	B-PP	O
11/19	11/19	CD	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

CURRENT	CURRENT	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
included	include	VBD	B-VP	O
Synthroid	Synthroid	JJ	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
and	and	CC	I-NP	O
Procan	Procan	NN	I-NP	O
SR	SR	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
SOCIAL	SOCIAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
twenty	twenty	JJ	I-NP	O
pack	pack	NN	I-NP	O
year	year	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
,	,	,	O	O
currently	currently	RB	B-ADVP	O
smoking	smoke	VBG	B-VP	O
half	half	PDT	B-NP	O
a	a	DT	I-NP	O
pack	pack	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lived	live	VBD	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
brother	brother	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
father	father	NN	I-NP	O
died	die	VBD	B-VP	O
at	at	IN	B-PP	O
94	94	CD	B-NP	O
from	from	IN	B-PP	O
cancer	cancer	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
was	be	VBD	B-VP	O
97.5	97.5	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
91/48	91/48	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
48	48	CD	B-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
three	three	CD	B-NP	O
liters	liter	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
weight	weight	NN	B-NP	O
115	115	CD	B-NP	O
pounds	pound	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
,	,	,	O	O
oriented	orient	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
responsive	responsive	JJ	B-ADJP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
Supple	Supple	NN	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
carotids	carotid	NNS	I-NP	O
without	without	IN	B-PP	O
bruits	bruit	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
jugular	jugular	JJ	B-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
5	5	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NNS	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
.	.	.	O	O

CARDIAC	CARDIAC	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
non-displaced	non-displaced	JJ	I-NP	O
point	point	NN	I-NP	O
of	of	IN	B-PP	O
maximal	maximal	JJ	B-NP	O
intensity	intensity	NN	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
without	without	IN	B-PP	O
murmurs	murmur	NNS	B-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
non-tender	non-tender	JJ	I-NP	O
,	,	,	I-NP	O
and	and	CC	I-NP	O
non-distended	non-distended	JJ	I-NP	O
.	.	.	O	O

RECTAL	RECTAL	NN	B-NP	O
:	:	:	O	O
Guaiac	Guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Ward	Ward	NNP	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Negative	Negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
cyanosis	cyanosis	NN	B-NP	O
and	and	CC	I-NP	O
edema	edema	NN	I-NP	B-protein
and	and	CC	I-NP	I-protein
2	2	CD	I-NP	I-protein
+	+	SYM	I-NP	O
femoral	femoral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
without	without	IN	B-PP	O
bruits	bruit	NNS	B-NP	O
.	.	.	O	O

NEUROLOGICAL	NEUROLOGICAL	NN	B-NP	O
:	:	:	O	O
Non-contributory	Non-contributory	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
sodium	sodium	NN	I-NP	O
was	be	VBD	B-VP	O
141	141	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
4.5	4.5	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
0.7	0.7	CD	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
LDH	LDH	NN	I-NP	B-protein
was	be	VBD	B-VP	O
290	290	CD	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
first	first	JJ	I-NP	O
CPK	CPK	NN	I-NP	B-protein
was	be	VBD	B-VP	O
53	53	CD	B-NP	O
,	,	,	O	O
cholesterol	cholesterol	NN	B-NP	O
was	be	VBD	B-VP	O
222	222	CD	B-NP	O
,	,	,	O	O
PA	PA	NN	B-NP	O
was	be	VBD	B-VP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
NAPA	NAPA	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.0	1.0	CD	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
or	or	CC	I-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Coronary	Coronary	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
with	with	IN	B-PP	O
0.15	0.15	CD	B-NP	O
/	/	SYM	I-NP	O
0.08	0.08	CD	I-NP	O
/	/	SYM	I-NP	O
0.2	0.2	CD	I-NP	O
,	,	,	I-NP	O
0.5	0.5	CD	I-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
in	in	IN	B-PP	O
F	F	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
Q	Q	NN	I-NP	B-DNA
or	or	CC	I-NP	O
flipped	flipped	JJ	I-NP	O
T	T	NN	I-NP	O
waves	wave	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Coronary	Coronary	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
,	,	,	O	O
put	put	VBN	B-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
kept	keep	VBD	B-VP	O
on	on	IN	B-PP	O
Heparin	Heparin	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
held	hold	VBD	B-VP	O
off	off	RP	B-PRT	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
beta	beta	NN	I-NP	O
blockade	blockade	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
often	often	RB	B-ADVP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
50	50	CD	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
to	to	TO	B-PP	O
90	90	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
intravenous	intravenous	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
some	some	DT	B-NP	O
fluid	fluid	NN	I-NP	O
boluses	bolus	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
started	start	VBD	B-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
simvastatin	simvastatin	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
and	and	CC	O	O
discussed	discuss	VBN	B-NP	O
smoking	smoking	NN	I-NP	O
cessation	cessation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
in	in	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
peak	peak	JJ	I-NP	I-protein
CK	CK	NN	I-NP	I-protein
was	be	VBD	B-VP	O
789	789	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MB	MB	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
79.2	79.2	CD	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
was	be	VBD	B-VP	O
20	20	CD	B-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
CPK	CPK	NN	I-NP	B-protein
drifted	drift	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
695	695	CD	B-NP	O
to	to	TO	B-PP	O
604	604	CD	B-NP	O
with	with	IN	B-PP	O
MB	MB	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
46.9	46.9	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Heparin	Heparin	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
8/5/96	8/5/96	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
2/23/96	2/23/96	CD	B-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
encouraged	encourage	VBN	I-VP	O
to	to	TO	I-VP	O
get	get	VB	I-VP	O
up	up	RP	B-PRT	O
and	and	CC	O	O
walk	walk	VB	B-VP	O
around	around	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
so	so	RB	B-ADVP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
recurrence	recurrence	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
after	after	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
on	on	IN	B-PP	O
8/5/96	8/5/96	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Heparin	Heparin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
pain	pain	NN	B-NP	O
free	free	JJ	B-ADJP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
2/27/96	2/27/96	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
modified	modified	JJ	I-NP	O
Bruce	Bruce	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
went	go	VBD	B-VP	O
seven	seven	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
twenty	twenty	CD	B-NP	O
seconds	second	NNS	I-NP	O
stopping	stop	VBG	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
maximal	maximal	JJ	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
89	89	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
2	2	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
downsloping	downslope	VBG	B-VP	O
depressions	depression	NNS	B-NP	O
in	in	IN	B-PP	O
V4	V4	NN	B-NP	O
and	and	CC	I-NP	O
V5	V5	NN	I-NP	O
that	that	WDT	B-NP	O
developed	develop	VBD	B-VP	O
with	with	IN	B-PP	O
exercise	exercise	NN	B-NP	O
and	and	CC	O	O
persisted	persist	VBD	B-VP	O
into	into	IN	B-PP	O
recovery	recovery	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
highly	highly	RB	B-ADJP	O
predictive	predictive	JJ	I-ADJP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
discussed	discuss	VBD	B-VP	O
doing	do	VBG	I-VP	O
a	a	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
kept	keep	VBD	B-VP	O
her	her	PRP$	B-NP	O
NPO	NPO	NN	I-NP	B-protein
.	.	.	O	O

An	An	DT	B-NP	O
hour	hour	NN	I-NP	O
later	later	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
8/10	8/10	CD	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
pain	pain	NN	B-NP	O
free	free	JJ	B-ADJP	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
could	could	MD	B-VP	O
be	be	VB	I-VP	O
done	do	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
thirty	thirty	CD	B-NP	O
minutes	minute	NNS	I-NP	O
after	after	IN	B-PP	O
that	that	DT	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
again	again	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
8/10	8/10	CD	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
EKG	EKG	NN	I-NP	O
showed	show	VBD	B-VP	O
2-3	2-3	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
in	in	IN	B-PP	O
V4	V4	NN	B-NP	O
through	through	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
with	with	IN	B-PP	O
pseudonormalization	pseudonormalization	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
aVF	aVF	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
V3	V3	NN	B-NP	B-protein
through	through	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
6/10	6/10	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Heparin	Heparin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
put	put	VBN	B-VP	O
on	on	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
tolerating	tolerate	VBG	B-VP	O
it	it	PRP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
six	six	CD	B-NP	O
sublinguals	sublingual	NNS	I-NP	O
and	and	CC	O	O
8	8	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
morphine	morphine	NN	B-NP	O
without	without	IN	B-PP	O
relief	relief	NN	B-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
60	60	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
100/60	100/60	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Catheterization	Catheterization	NNP	I-NP	O
Laboratory	Laboratory	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
showed	show	VBD	B-VP	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
ventricle	ventricle	NN	I-NP	O
24/4	24/4	CD	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
of	of	IN	B-PP	O
8	8	CD	B-NP	O
,	,	,	O	O
arterial	arterial	JJ	B-NP	O
110/70	110/70	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descending	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
subtotal	subtotal	JJ	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
opened	open	VBN	I-VP	O
with	with	IN	B-PP	O
PTCA	PTCA	NN	B-NP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
Heparin	Heparin	NN	B-NP	O
for	for	IN	B-PP	O
another	another	DT	B-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
PTCA	PTCA	NN	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
the	the	DT	B-NP	O
Heparin	Heparin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
pain	pain	NN	B-ADJP	O
free	free	JJ	I-ADJP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization/PTCA	catheterization/PTCA	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
8/9/96	8/9/96	CD	B-NP	O
with	with	IN	B-PP	O
follow-up	follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rumphol	Rumphol	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
TSH	TSH	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
given	give	VBN	I-VP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
TSH	TSH	NN	I-NP	O
was	be	VBD	B-VP	O
1.0	1.0	CD	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
's	's	POS	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
complication	complication	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
,	,	,	O	O
ECASA	ECASA	NN	B-NP	O
,	,	,	O	O
325	325	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Synthroid	Synthroid	NNP	B-NP	O
125	125	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
1/150	1/150	CD	I-NP	O
sublingually	sublingually	RB	I-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
q.	q.	NN	I-NP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
times	time	NNS	I-NP	O
three	three	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
simvastatin	simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
FOLLOW-UP	FOLLOW-UP	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Stikeleather	Stikeleather	NNP	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
ERIN	ERIN	NNP	B-NP	O
B.	B.	NNP	I-NP	O
LENHART	LENHART	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
UC46	UC46	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
JUDSON	JUDSON	NNP	B-NP	O
L.	L.	NNP	I-NP	O
WELANDER	WELANDER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
XO6	XO6	NNP	I-NP	O
CP465/0033	CP465/0033	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
60431	60431	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

CHDZAN2O1N	CHDZAN2O1N	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
3/18/96	3/18/96	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/23/96	9/23/96	CD	B-NP	O
cc	cc	NN	I-NP	O
:	:	:	O	O
Enoch	Enoch	NNP	B-NP	O
Billings	Billings	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
Cardiovascular	Cardiovascular	NNP	I-NP	O
Division	Division	NNP	I-NP	O
,	,	,	O	O
BVH	BVH	NNP	B-NP	O

